Install
Hard data and deep insights on clinical trials strategy & operations
- 213articles · 90d
- 2+ day agolatest article
- Jun 15, 2026earliest in window
- 92%with images
- 322avg words
- Medical 207
- Health & Wellness 197
- Health 154
- Science & Technology 30
- Economy, Business & Finance 26
- Business & Industrial 13
- Finance & Business 3
- Science & Nature 2
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Veradermics stock jumps again on female hair loss drug win
1+ mon, 3+ week ago (506+ words) This is the second positive Phase II readout of VDPHL01, which analysts note could represent a $2bn+ market opportunity Veradermics has seen another jump in its stock price as its hair loss drug showed benefit in women with androgenetic alopecia (AGA). Patients…...
Q32 Bio reports 36-week data from SIGNAL-AA trial’s Part B in alopecia areata
1+ mon, 4+ week ago (394+ words) Q32 Bio has reported positive 36-week top line data from Part B of the SIGNAL-AA Phase IIa trial of bempikibart for patients with severe or very severe alopecia areata (AA). Bempikibart is a fully human antibody that targets the interleukin-7 receptor…...